Hong Kyun Kim
Overview
Explore the profile of Hong Kyun Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shim S, Kim M, Yae C, Kang Y, Do J, Kim H, et al.
J Am Med Inform Assoc
. 2025 Mar;
PMID: 40037789
Objective: This study aimed to develop a novel multi-stage self-supervised learning model tailored for the accurate classification of optical coherence tomography (OCT) images in ophthalmology reducing reliance on costly labeled...
2.
Kim D, Yi S, Park B, Eom S, Kang S, Kim D, et al.
ACS Biomater Sci Eng
. 2025 Feb;
11(3):1834-1846.
PMID: 39977337
Nanofiber (NF) membranes have demonstrated considerable potential in cellular transmigration studies due to their resemblance to the biophysical properties of basement membranes, enabling cellular behaviors that closely mimic those observed...
3.
Hong S, Woo M, Eom Y, Kim H, Yoon K, Na K, et al.
J Ocul Pharmacol Ther
. 2025 Feb;
41(2):65-74.
PMID: 39907215
To investigate the effectiveness of re-esterified triglyceride form of omega 3 (rTG-omega 3) on patients with meibomian gland dysfunction (MGD) after cataract surgery. This multicenter, randomized, investigator-blinded, clinical study was...
4.
Yoon S, Kim E, You I, Choi C, Kim J, Song J, et al.
BMC Ophthalmol
. 2025 Jan;
25(1):37.
PMID: 39844141
Purpose: To assess the clinical efficacy of 0.1% cyclosporine A (CsA) in dry eye patients who have shown inadequate responses to previous treatment with 0.05% CsA. Design: This study was...
5.
Seong D, Lee E, Kim Y, Yae C, Choi J, Kim H, et al.
NPJ Digit Med
. 2024 Nov;
7(1):308.
PMID: 39501083
Corneal transplantation is the primary treatment for irreversible corneal diseases, but due to limited donor availability, bioengineered corneal equivalents are being developed as a solution, with biocompatibility, structural integrity, and...
6.
Yi S, Kim J, Kim M, Yae C, Kim K, Kim H
Ocul Surf
. 2024 Sep;
34:370-380.
PMID: 39332677
Purpose: This study aimed to investigate the therapeutic potential of extracellular vesicles (EVs) derived from human amniotic epithelial cells (hAEC-EVs) for Dry Eye Disease (DED) treatment. Methods: Highly purified EVs...
7.
Park W, Seo H, Kim J, Hong Y, Song H, Joo B, et al.
Nat Commun
. 2024 Apr;
15(1):2828.
PMID: 38565532
Tears have emerged as a promising alternative to blood for diagnosing diabetes. Despite increasing attempts to measure tear glucose using smart contact lenses, the controversy surrounding the correlation between tear...
8.
Kang Y, Park D, Ryu G, Kim H, Kim D, Do J
Sci Rep
. 2024 Mar;
14(1):7279.
PMID: 38538735
No abstract available.
9.
Kang Y, Park D, Ryu G, Kim H, Kim D, Do J
Sci Rep
. 2024 Mar;
14(1):6181.
PMID: 38485976
This study aimed to compare the outcomes of flanged intraocular lens (IOL) fixation with new IOL exchange after dislocated IOL removal and repositioned dislocated IOL in patients with IOL dislocation....
10.
Seo H, Hong Y, Chung W, Park W, Lee J, Kim H, et al.
Sci Adv
. 2024 Feb;
10(6):eadk7805.
PMID: 38324695
Glaucoma causes irreversible vision loss due to optic nerve damage and retinal cell degeneration. Since high intraocular pressure (IOP) is a major risk factor for glaucoma development, accurate IOP measurement...